| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cellular communication network factor 3 | 0.554 | 0.615 | 6.6E-03 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2008 | 2015 | ||||||||
|
phospholipase A2 group IVA | 0.496 | 0.846 | 6.0E-05 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2019 | 2019 | ||||||||
|
mindbomb E3 ubiquitin protein ligase 1 | 0.438 | 0.769 | 3.4E-88 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2002 | 2018 | ||||||||
|
ADAM metallopeptidase domain 17 | 0.453 | 0.808 | 1.00 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2015 | 2018 | ||||||||
|
microRNA 552 | 0.705 | 0.269 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2019 | 2019 | |||||||||
|
KH RNA binding domain containing, signal transduction associated 1 | 0.457 | 0.846 | 0.99 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2014 | 2018 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1998 | 2019 | ||||||||
|
nucleoporin 62 | 0.470 | 0.885 | 0.95 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2014 | 2018 | ||||||||
|
general transcription factor IIH subunit 1 | 0.469 | 0.846 | 0.99 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2014 | 2018 | ||||||||
|
lysine methyltransferase 5A | 0.633 | 0.538 | 0.99 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2016 | 2018 | ||||||||
|
marker of proliferation Ki-67 | 0.431 | 0.808 | 1.3E-28 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 1998 | 2018 | ||||||||
|
microRNA 381 | 0.584 | 0.654 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2016 | 2018 | |||||||||
|
dynactin subunit 4 | 0.472 | 0.846 | 0.73 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2014 | 2018 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2011 | 2019 | ||||||||
|
cyclin dependent kinase 14 | 0.659 | 0.423 | 2.5E-08 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2017 | 2018 | ||||||||
|
X-ray repair cross complementing 3 | 0.505 | 0.769 | 1.9E-10 |
|
disease | 0.030 | None | 0.667 | 3 | 1 | 2015 | 2018 | ||||||||
|
gamma-glutamylcyclotransferase | 0.552 | 0.808 | 1.4E-04 |
|
disease | 0.030 | None | 0.667 | 3 | 0 | 2011 | 2018 | ||||||||
|
high mobility group box 1 | 0.368 | 0.923 | 0.82 |
|
disease | 0.100 | None | 0.750 | 12 | 0 | 2014 | 2018 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.040 | None | 0.750 | 4 | 1 | 1999 | 2014 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 3 | 2008 | 2018 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2005 | 2016 | ||||||||
|
sequestosome 1 | 0.428 | 0.885 | 8.6E-04 |
|
disease | 0.040 | None | 0.750 | 4 | 1 | 2009 | 2018 | ||||||||
|
ATRX chromatin remodeler | 0.452 | 0.808 | 1.00 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2011 | 2018 | ||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
disease | 0.050 | None | 0.800 | 5 | 0 | 2016 | 2019 | |||||||||
|
RecQ like helicase 4 | 0.496 | 0.808 | 3.3E-35 |
|
disease | 0.100 | None | 0.818 | 11 | 0 | 2003 | 2018 |